25 years of interferon-based treatment of chronic hepatitis C: an epoch coming to an end

被引：0
|
作者：
Markus H. Heim
机构：
[1] University of Basel,Markus H. Heim is at the Department of Biomedicine, Switzerland and at the Division of Gastroenterology and Hepatology
[2] 4031 Basel,undefined
[3] University Hospital Basel,undefined
[4] 4031 Basel,undefined
[5] Switzerland.,undefined
来源：
Nature Reviews Immunology | 2013年 / 13卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The mechanisms underlying the antiviral activity of type I interferons (IFNs) are still unclear, but IFNα has long been used in the treatment of chronic hepatitis C (CHC). While reviewing the history of IFNα-based CHC treatment, Markus H. Heim highlights the remaining questions and discusses the future challenges of IFN-based therapies.
引用
收藏
页码：535 / 542
页数：7
相关论文
共 50 条
12345